Global AI-Powered Drug Discovery Software 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06251657

Publication Date:

June 27, 2025

Pages:

135

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global AI-Powered Drug Discovery Software market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
AI-Powered Drug Discovery Software is a software system that uses artificial intelligence technology for drug discovery and development. It uses advanced artificial intelligence algorithms and technologies such as machine learning, deep learning, and data mining to help drug researchers perform data analysis, prediction, and optimization during the drug discovery process.
United States market for AI-Powered Drug Discovery Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for AI-Powered Drug Discovery Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for AI-Powered Drug Discovery Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key AI-Powered Drug Discovery Software players cover AtomWise, AutoDock, BenevolentAI, CCD Vault, Compound Assist, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淎I-Powered Drug Discovery Software Industry Forecast鈥� looks at past sales and reviews total world AI-Powered Drug Discovery Software sales in 2024, providing a comprehensive analysis by region and market sector of projected AI-Powered Drug Discovery Software sales for 2025 through 2031. With AI-Powered Drug Discovery Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-Powered Drug Discovery Software industry.
This Insight Report provides a comprehensive analysis of the global AI-Powered Drug Discovery Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-Powered Drug Discovery Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global AI-Powered Drug Discovery Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-Powered Drug Discovery Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-Powered Drug Discovery Software.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-Powered Drug Discovery Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
On-Premise
Cloud-Based
Segmentation by Application:
Pharmaceutical Company
Academic Research Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AtomWise
AutoDock
BenevolentAI
CCD Vault
Compound Assist
Cyclica
DrugDev Spark
DrugPatentWatch
DSG Drug Safety
Epocrates
InSilicoTrials
Insilico Medicine
Micro Tracker
PEPID PDC
厂肠丑谤枚诲颈苍驳别谤
Thermo Scientific
XtalPi

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global AI-Powered Drug Discovery Software 麻豆原创 Size (2020-2031)
2.1.2 AI-Powered Drug Discovery Software 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for AI-Powered Drug Discovery Software by Country/Region (2020, 2024 & 2031)
2.2 AI-Powered Drug Discovery Software Segment by Type
2.2.1 On-Premise
2.2.2 Cloud-Based
2.3 AI-Powered Drug Discovery Software 麻豆原创 Size by Type
2.3.1 AI-Powered Drug Discovery Software 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global AI-Powered Drug Discovery Software 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 AI-Powered Drug Discovery Software Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Academic Research Institution
2.4.3 Others
2.5 AI-Powered Drug Discovery Software 麻豆原创 Size by Application
2.5.1 AI-Powered Drug Discovery Software 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global AI-Powered Drug Discovery Software 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 AI-Powered Drug Discovery Software 麻豆原创 Size by Player
3.1 AI-Powered Drug Discovery Software 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global AI-Powered Drug Discovery Software Revenue by Player (2020-2025)
3.1.2 Global AI-Powered Drug Discovery Software Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global AI-Powered Drug Discovery Software Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-Powered Drug Discovery Software by Region
4.1 AI-Powered Drug Discovery Software 麻豆原创 Size by Region (2020-2025)
4.2 Global AI-Powered Drug Discovery Software Annual Revenue by Country/Region (2020-2025)
4.3 Americas AI-Powered Drug Discovery Software 麻豆原创 Size Growth (2020-2025)
4.4 APAC AI-Powered Drug Discovery Software 麻豆原创 Size Growth (2020-2025)
4.5 Europe AI-Powered Drug Discovery Software 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa AI-Powered Drug Discovery Software 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas AI-Powered Drug Discovery Software 麻豆原创 Size by Country (2020-2025)
5.2 Americas AI-Powered Drug Discovery Software 麻豆原创 Size by Type (2020-2025)
5.3 Americas AI-Powered Drug Discovery Software 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-Powered Drug Discovery Software 麻豆原创 Size by Region (2020-2025)
6.2 APAC AI-Powered Drug Discovery Software 麻豆原创 Size by Type (2020-2025)
6.3 APAC AI-Powered Drug Discovery Software 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-Powered Drug Discovery Software 麻豆原创 Size by Country (2020-2025)
7.2 Europe AI-Powered Drug Discovery Software 麻豆原创 Size by Type (2020-2025)
7.3 Europe AI-Powered Drug Discovery Software 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-Powered Drug Discovery Software by Region (2020-2025)
8.2 Middle East & Africa AI-Powered Drug Discovery Software 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa AI-Powered Drug Discovery Software 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global AI-Powered Drug Discovery Software 麻豆原创 Forecast
10.1 Global AI-Powered Drug Discovery Software Forecast by Region (2026-2031)
10.1.1 Global AI-Powered Drug Discovery Software Forecast by Region (2026-2031)
10.1.2 Americas AI-Powered Drug Discovery Software Forecast
10.1.3 APAC AI-Powered Drug Discovery Software Forecast
10.1.4 Europe AI-Powered Drug Discovery Software Forecast
10.1.5 Middle East & Africa AI-Powered Drug Discovery Software Forecast
10.2 Americas AI-Powered Drug Discovery Software Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.2.2 Canada 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.2.3 Mexico 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.2.4 Brazil 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.3 APAC AI-Powered Drug Discovery Software Forecast by Region (2026-2031)
10.3.1 China AI-Powered Drug Discovery Software 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.3.3 Korea 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.3.4 Southeast Asia 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.3.5 India 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.3.6 Australia 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.4 Europe AI-Powered Drug Discovery Software Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.4.2 France 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.4.3 UK 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.4.4 Italy 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.4.5 Russia 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.5 Middle East & Africa AI-Powered Drug Discovery Software Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.5.2 South Africa 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.5.3 Israel 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.5.4 Turkey 麻豆原创 AI-Powered Drug Discovery Software Forecast
10.6 Global AI-Powered Drug Discovery Software Forecast by Type (2026-2031)
10.7 Global AI-Powered Drug Discovery Software Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 AI-Powered Drug Discovery Software Forecast
11 Key Players Analysis
11.1 AtomWise
11.1.1 AtomWise Company Information
11.1.2 AtomWise AI-Powered Drug Discovery Software Product Offered
11.1.3 AtomWise AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 AtomWise Main Business Overview
11.1.5 AtomWise Latest Developments
11.2 AutoDock
11.2.1 AutoDock Company Information
11.2.2 AutoDock AI-Powered Drug Discovery Software Product Offered
11.2.3 AutoDock AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 AutoDock Main Business Overview
11.2.5 AutoDock Latest Developments
11.3 BenevolentAI
11.3.1 BenevolentAI Company Information
11.3.2 BenevolentAI AI-Powered Drug Discovery Software Product Offered
11.3.3 BenevolentAI AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 BenevolentAI Main Business Overview
11.3.5 BenevolentAI Latest Developments
11.4 CCD Vault
11.4.1 CCD Vault Company Information
11.4.2 CCD Vault AI-Powered Drug Discovery Software Product Offered
11.4.3 CCD Vault AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 CCD Vault Main Business Overview
11.4.5 CCD Vault Latest Developments
11.5 Compound Assist
11.5.1 Compound Assist Company Information
11.5.2 Compound Assist AI-Powered Drug Discovery Software Product Offered
11.5.3 Compound Assist AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Compound Assist Main Business Overview
11.5.5 Compound Assist Latest Developments
11.6 Cyclica
11.6.1 Cyclica Company Information
11.6.2 Cyclica AI-Powered Drug Discovery Software Product Offered
11.6.3 Cyclica AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Cyclica Main Business Overview
11.6.5 Cyclica Latest Developments
11.7 DrugDev Spark
11.7.1 DrugDev Spark Company Information
11.7.2 DrugDev Spark AI-Powered Drug Discovery Software Product Offered
11.7.3 DrugDev Spark AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 DrugDev Spark Main Business Overview
11.7.5 DrugDev Spark Latest Developments
11.8 DrugPatentWatch
11.8.1 DrugPatentWatch Company Information
11.8.2 DrugPatentWatch AI-Powered Drug Discovery Software Product Offered
11.8.3 DrugPatentWatch AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 DrugPatentWatch Main Business Overview
11.8.5 DrugPatentWatch Latest Developments
11.9 DSG Drug Safety
11.9.1 DSG Drug Safety Company Information
11.9.2 DSG Drug Safety AI-Powered Drug Discovery Software Product Offered
11.9.3 DSG Drug Safety AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 DSG Drug Safety Main Business Overview
11.9.5 DSG Drug Safety Latest Developments
11.10 Epocrates
11.10.1 Epocrates Company Information
11.10.2 Epocrates AI-Powered Drug Discovery Software Product Offered
11.10.3 Epocrates AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Epocrates Main Business Overview
11.10.5 Epocrates Latest Developments
11.11 InSilicoTrials
11.11.1 InSilicoTrials Company Information
11.11.2 InSilicoTrials AI-Powered Drug Discovery Software Product Offered
11.11.3 InSilicoTrials AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 InSilicoTrials Main Business Overview
11.11.5 InSilicoTrials Latest Developments
11.12 Insilico Medicine
11.12.1 Insilico Medicine Company Information
11.12.2 Insilico Medicine AI-Powered Drug Discovery Software Product Offered
11.12.3 Insilico Medicine AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Insilico Medicine Main Business Overview
11.12.5 Insilico Medicine Latest Developments
11.13 Micro Tracker
11.13.1 Micro Tracker Company Information
11.13.2 Micro Tracker AI-Powered Drug Discovery Software Product Offered
11.13.3 Micro Tracker AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Micro Tracker Main Business Overview
11.13.5 Micro Tracker Latest Developments
11.14 PEPID PDC
11.14.1 PEPID PDC Company Information
11.14.2 PEPID PDC AI-Powered Drug Discovery Software Product Offered
11.14.3 PEPID PDC AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 PEPID PDC Main Business Overview
11.14.5 PEPID PDC Latest Developments
11.15 厂肠丑谤枚诲颈苍驳别谤
11.15.1 厂肠丑谤枚诲颈苍驳别谤 Company Information
11.15.2 厂肠丑谤枚诲颈苍驳别谤 AI-Powered Drug Discovery Software Product Offered
11.15.3 厂肠丑谤枚诲颈苍驳别谤 AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 厂肠丑谤枚诲颈苍驳别谤 Main Business Overview
11.15.5 厂肠丑谤枚诲颈苍驳别谤 Latest Developments
11.16 Thermo Scientific
11.16.1 Thermo Scientific Company Information
11.16.2 Thermo Scientific AI-Powered Drug Discovery Software Product Offered
11.16.3 Thermo Scientific AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Thermo Scientific Main Business Overview
11.16.5 Thermo Scientific Latest Developments
11.17 XtalPi
11.17.1 XtalPi Company Information
11.17.2 XtalPi AI-Powered Drug Discovery Software Product Offered
11.17.3 XtalPi AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 XtalPi Main Business Overview
11.17.5 XtalPi Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.